Stephen White, MD
Vascular Surgery · Shreveport, LANPI 1164435475
Payments from drug & device makers
What this record shows
14 manufacturers reported payments, led by Spineart USA Inc at 57.5% of the total. 2025 is the largest year on record at $1,575, more than ten times the $71 reported in 2019. That places this record below the midpoint for vascular surgery clinicians in LA, where the typical reported total is $4,548.
Across 36 payments — averaging $72.48 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Spineart USA Inc$2K
- Medtronic$258
- Silk Road Medical, Inc.$245
- Endologix LLC$171
- W. L. Gore & Associates, Inc.$167
- Lemaitre Vascular, Inc.$43
- plus $225 from 8 others
What the payments were for
- Consulting fees$1,50057%
- Food & beverage$1,10943%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Spineart USA Inc | 1 | $1,500 |
| Medtronic(2 entities) | 14 | $258 |
| Silk Road Medical, Inc. | 5 | $245 |
| Endologix LLC | 1 | $171 |
| W. L. Gore & Associates, Inc. | 3 | $167 |
| Lemaitre Vascular, Inc. | 3 | $43 |
| Baxter Healthcare | 1 | $42 |
| Boston Scientific | 2 | $40 |
| Inari Medical, Inc. | 1 | $37 |
| AbbVie | 1 | $25 |
| Shire North American Group Inc | 1 | $23 |
| Getinge USA Sales, LLC | 1 | $22 |
| Surmodics, Inc. | 1 | $19 |
| Bard Peripheral Vascular, Inc. | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$2,609 in reported general payments places this provider in the 30th percentile of 65 vascular surgery providers in Louisiana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 34 | $18,983 |
| Cilostazol | 81 | $1,218 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 85 | $431 |
| ClopidogrelClopidogrel Bisulfate | 57 | $335 |
Paid to pharmacies, not to this prescriber.
Other vascular surgery in Shreveport
- Paul PerkowskiShreveport$41K
- Chiranjiv VirkShreveport$7K
- Miles SugarShreveport$4K
- Fredrick KnightShreveport$942
- Milton SlocumShreveport$610
- Robert BarrettShreveport$557
- Charles KnightShreveport$333
- Michael Conners IiiBaton Rouge$70K
- Gregory CrenshawMetairie$67K
- James CravenBaton Rouge$65K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.